Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Rash Following Medication Change Prompts Evaluation of Excipient Allergy
Two Peaks in MIS-C Followed COVID-19 Peaks in the US
FDA: Complications Up for 2 Brands of Surgical Mesh Used in Breast Reconstruction
Skin Rashes Occur in Considerable Number of SARS-CoV-2 Cases
Guselkumab Benefits Observed Through 2 Years in Psoriatic Arthritis Trial
Rapid Relief Restoring Cream Added to AmLactin Product Line
FDA to Review Difelikefalin for Chronic Kidney Disease-Associated Pruritus
Actemra Gains New Indication for Systemic Sclerosis-Associated Interstitial Lung Disease
Baricitinib Improves Hair Regrowth in Alopecia Areata Trial
Cutaneous Findings Described for Children With MIS-C
Amgen Looks to Expand Apremilast Plaque Psoriasis Indication
Ruxolitinib Cream Under Review for Atopic Dermatitis
Klisyri Ointment Now Available for Actinic Keratosis
Tirbanibulin Superior to Placebo for Actinic Keratosis
Bimekizumab May be Superior to Ustekinumab for Plaque Psoriasis
Gusacitinib Fast Tracked for Chronic Hand Eczema
Deucravacitinib Superior to Apremilast in Second Psoriasis Trial
Amzeeq Labeling Updated With Antimicrobial Resistance Data
